Roche

CINtec® Histology is a pioneering brand in the field of in vitro diagnostics, dedicated to enhancing the accuracy of cervical cancer detection. As the only 510(k) cleared p16 immunohistochemistry biomarker test for cervical biopsy evaluation, CINtec® Histology significantly improves diagnostic consistency among pathologists. The test aids in identifying high-grade cervical lesions, often overlooked by traditional methods, thus ensuring that patients receive the necessary treatment without the risk of overtreatment.

CINtec® Histology emphasizes objectivity in diagnostic interpretation and provides pathologists with critical insights that lead to better patient outcomes. The brand's commitment to innovation is evident in its robust portfolio, which includes comprehensive diagnostic products, training resources, and technical support.

With a clear focus on cervical cancer diagnostics, CINtec® Histology empowers healthcare professionals and paves the way for more accurate and informed medical decisions. Discover the difference that enhanced diagnostic performance can make with CINtec® Histology.